A fitness assay for comparing RNAi effects across multiple C. elegans genotypes by Elvin, Mark et al.
METHODOLOGY ARTICLE Open Access
A fitness assay for comparing RNAi effects across
multiple C. elegans genotypes
Mark Elvin
1†, Laurens B Snoek
2†, Martin Frejno
1, Ulrike Klemstein
1, Jan E Kammenga
2* and Gino B Poulin
1
Abstract
Background: RNAi technology by feeding of E. coli containing dsRNA in C. elegans has significantly contributed to
further our understanding of many different fields, including genetics, molecular biology, developmental biology
and functional genomics. Most of this research has been carried out in a single genotype or genetic background.
However, RNAi effects in one genotype do not reveal the allelic effects that segregate in natural populations and
contribute to phenotypic variation.
Results: Here we present a method that allows for rapidly comparing RNAi effects among diverse genotypes at an
improved high throughput rate. It is based on assessing the fitness of a population of worms by measuring the
rate at which E. coli is consumed. Critically, we demonstrate the analytical power of this method by QTL mapping
the loss of RNAi sensitivity (in the germline) in a recombinant inbred population derived from a cross between
Bristol and a natural isolate from Hawaii. Hawaii has lost RNAi sensitivity in the germline. We found that
polymorphisms in ppw-1 contribute to this loss of RNAi sensitivity, but that other loci are also likely to be
important.
Conclusions: In summary, we have established a fast method that improves the throughput of RNAi in liquid, that
generates quantitative data, that is easy to implement in most laboratories, and importantly that enables QTL
mapping using RNAi.
Background
The first genome-wide RNAi screen performed in
C. elegans proved to be a milestone, for the first time
each predicted gene of a metazoan could be inactivated
and the observed effects characterized in a systematic
way [1]. Since then, steady improvements have been
made to the RNAi feeding method, in particular the
possibility to perform RNAi screens in liquid in a 96-
well format [2]. The current methodology is appropriate
to address gene function in either a wild type back-
ground or a mutated background. However, the current
method becomes very difficult to apply when the ques-
tion to be addressed is to determine the role of a parti-
cular gene in relation to multiple genetic backgrounds
or genotypes (Figure 1). This problem mainly occurs
because RNAi effects were not quantifiable when
performed at a high throughput rate. We sought to
solve this problem by developing a high throughput
method that generates quantitative data fully amenable
to statistical analyzes that allows us to tease apart the
contribution of individual genetic backgrounds to a spe-
cific process.
The basic principle of the method is to assess the fit-
ness of a population of animals by measuring the rate at
which E. coli is consumed. Typically, an experiment
assesses the fitness over a period of 8 days. This generates
Fitness Curves (FCs), which are amenable to statistics.
Various analyzes can be performed on the curves using
parameters such as the slope, the mean, the time
required to consume 50% of the food, the difference
between first and last readings, or even the surface above
t h ea r e ao ft h ec u r v e .H e r e ,w em a i n l yu s e dv a r i a t i o no n
the slope, since this parameter can capture most of the
effects observed on the FCs.
We demonstrate that our approach is robust by map-
ping the C. elegans loss of RNAi sensitivity trait using
diverse genetic backgrounds. We took advantage of
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mating two diverse genetic backgrounds N2 (Bristol) and
CB4856 (Hawaii). This RIL population has extensively
been used to map a range of quantitative traits [3-5].
Hence, we used these previously described RILs [6-8] and
a number of new RILs (Additional file 1, Table S1). The
N2 (Bristol) background is RNAi sensitive whereas the
CB4856 (Hawaii) background is RNAi insensitive in the
germline [9]. Using Quantitative Trait Loci (QTL) map-
ping, we identified ppw-1, a gene causal to the RNAi
insensitivity of the CB4856 germline [9]. Importantly, we
performed a detailed genotype-to-phenotype analysis that
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Figure 1 The usefulness of the Fitness Assay. A) RNAi by feeding in liquid has increased the throughput considerably to address gene
function within a genetic background, but this method remains a qualitative or semi-quantitative method at best. B) The Fitness Assay is a
method that measures the rate at which food is consumed. The Fitness Assay produces quantitative data from RNAi treatments for each genetic
background tested. These data are then used to address gene function in relation to genetic backgrounds. C) Potentially, the Fitness Assay could
be adapted to measure the effects of drug treatments on various genetic backgrounds and address drug activity in relation to these genetic
backgrounds.
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Page 2 of 14provides evidence that loss of RNAi sensitivity is a com-
plex trait, in which ppw-1 is one of probably several
RNAi sensitivity modifiers. In total, 56 genetic back-
grounds were tested using 12 RNAi treatments. Analyz-
ing such a number of genetic backgrounds has never
been performed before, but critically this is the first time
that quantitative data have been produced for RNAi
treatments in C. elegans.
Results
Bristol (N2) and Hawaii (CB4856) respond differently to
RNAi treatments
Bristol and Hawaii react very differently when exposed to
RNAi. RNAi in Bristol is highly effective, but in Hawaii
RNAi sensitivity for germline expressed genes has been
lost [9]. Therefore, we reasoned that our fitness assay
should be ideal to differentiate between these two RNAi
sensitivity behaviors. For example, if we target an essen-
tial gene that functions in the germline, Bristol will die,
but not Hawaii. We performed RNAi in both strains on a
p a n e lo f1 2R N A ic l o n e s :f o u rc l o n e s( t a r g e t i n gpar-1,
par-6, pos-1,a n dmel-26) are known to be more effective
in Bristol than in Hawaii [9]; two clones (targeting rab-5
and tag-214)a r ek n o w nt ob ee f f e c t i v ei nb o t hn a t u r a l
isolates [9]; one clone (targeting lin-31) is used as a nega-
tive control since it affects vulval development, a non-
essential organ for viability [10]; four clones (targeting
smo-1, mpk-1, gld-1,a n dlet-502) have never been tested
before for comparison between Bristol and Hawaii; and
the empty vector clone is used as a control or a reference.
We have analyzed the data generated from the fitness
assay in two ways: i) by comparing each RNAi condition
to the empty vector for each strain and ii) by analyzing
whether Bristol responds differently from Hawaii to spe-
cific RNAi treatments.
In the first part of the analysis, we found that eight out
of eleven RNAi treatments caused a reduction in fitness
in Bristol (Figure 2 (top panels show three examples) and
Table 1). These RNAi treatments have been previously
shown to cause lethality, to reduce fertility, or to reduce
growth rate [1], all these parameters are predicted to
affect the rate of food consumption. We were not able to
detect an effect with let-502 and mpk-1(RNAi), indicating
that RNAi conditions in liquid may have been less effi-
cient for these specific cases. RNAi by feeding has been
shown to produce a high rate of false negative results but
a very low rate of false positive results [1]. We next ana-
lyzed the FCs produced in the Hawaii strain. Only the
rab-5(RNAi) and tag-214(RNAi) treatments can produce
FCs that are significantly different from the reference
(ev), likely because these genes are functional outside the
germline (Figure 2 (middle 3 panels) and Table 1).
In the second and most innovative part of our analy-
sis, we compared the FCs obtained from the same RNAi
treatment between Bristol and Hawaii. Accordingly,
Bristol and Hawaii do not respond differentially to
empty vector, mpk-1(RNAi),t h ec o n t r o llin-31(RNAi),
and rab-5(RNAi) (Table 1). However, we observed dif-
ferential responses with RNAi targeting mel-26, pos-1,
par-1, par-6, gld-1, smo-1 and let-502 (Figure 2 (bottom
3 panels) and Table 1). Surprisingly, tag-214 appears to
produce a differential response suggesting that the RNAi
treatment was more effective in Hawaii than Bristol.
Detailed analysis would be required to confirm this
observation. Taken together, these results show that
RNAi treatment effects can produce data consistent
with previous studies [1,2]. Importantly, these data can
be quantified when applied onto diverse genetic back-
grounds or genotypes.
PPW-1 is a modifier of RNAi sensitivity
The differential effect for germline RNAi sensitivity
observed between Bristol and Hawaii is attributed to
PPW-1 [9]. PPW-1 is an RNA binding protein of the
PIWI family, which is important to maintain RNAi sensi-
tivity of genes presumably active in the germline. How-
ever, RNAi sensitivity can also be mediated at a general
level, such as in the case of an rde-1 mutant, in which
RNAi sensitivity is totally lost [11,12]. To distinguish
between these general and germline-specific effects, we
tested rde-1 and ppw-1 mutants and compared them with
Bristol and Hawaii, respectively. Looking at the FCs, we
can readily detect that the rde-1 mutant lost total RNAi
sensitivity (Figure 3). Therefore, all the RNAi effects
observed in Bristol require the general RNAi machinery
and cannot be attributed to generic culture condition pro-
blems. In contrast, the ppw-1 mutant FCs nicely phenoco-
pies the FCs obtained from the Hawaii strain (Figure 3).
Therefore, loss of RNAi sensitivity in Hawaii is consistent
with ppw-1 deleterious polymorphisms [9].
RNAi treatments of 56 RILs identifies a shared QTL at the
ppw-1 locus
Polymorphisms in ppw-1 appear to explain the loss of
germline RNAi sensitivity in Hawaii. However, even
though the ppw-1 mutant behavior is consistent with this
view, the previous study [9] did not address or rule out
whether other natural modifiers exist. Since our method is
able to detect differential RNAi behaviors at a quantitative
level, we tested if we could map the loss of germline RNAi
sensitivity trait using QTL analysis. For this purpose, we
exposed 56 RILs generated from a cross between Bristol
and Hawaii [6-8], and their respective parental strains, to
our 12 RNAi treatments. Interestingly, we found a highly
significant QTL on Chromosome I, close to the ppw-1
locus (Figure 4). This QTL is especially strong for mel-26
(RNAi), smo-1(RNAi), par-1(RNAi), par-6(RNAi) and pos-1
(RNAi) and harbours ppw-1.
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Page 3 of 14A genotype-to-phenotype analysis suggest that loss of
RNAi sensitivity is a complex trait
Even though ppw-1 was previously identified as an
important contributor to loss of RNAi sensitivity, and
that our results so far support this view, we tested at an
individual level how well correlated the ppw-1 genotype
is to the loss of germline RNAi sensitivity phenotype. We
first sequenced the ppw-1 locus for 31 RILs and then
analyzed whether the genotype can predict the pheno-
type, herein loss of germline RNAi sensitivity. The pre-
diction is that a genotype that matches with Hawaii ppw-
1 polymorphisms should cause loss of RNAi sensitivity in
the germline. Vice versa, the RILs with Bristol ppw-1
polymorphisms should remain RNAi sensitive. Surpris-
ingly, we found that in about 25% of the cases, we could
not categorize the phenotype to either Bristol-like or
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Figure 2 Comparison of RNAi treatments between Bristol and Hawaii. Shown are three representative RNAi treatments that illustrate RNAi
effects in Bristol (upper panel), in Hawaii (middle panel), and their differential effects in Bristol versus Hawaii (lower panel). The negative control
is lin-31(RNAi) and the reference is the empty vector (ev). Relative OD at 600 nm on the y-axis, time (in hours) on the x-axis. The RNAi treatment
is indicated in the grey box. N2 is shown in red, CB in blue.
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Page 4 of 14Hawaii-like behavior (Figure 5A). However, if we focused
on the 23 RILs (~75%) that can be categorized as either
Bristol-like (12 RILs) or Hawaii-like (11 RILs), we found
that in ~83% of the cases, the loss of RNAi sensitivity
trait correlates to Hawaii ppw-1 (Figure 5B). Taken
together, these results provide new evidence that loss of
RNAi sensitivity in Hawaii is not entirely due to poly-
morphisms in ppw-1 and that other important RNAi sen-
sitivity modifiers must exist, even though ppw-1 is strong
predictor of germline RNAi sensitivity [9].
Factors affecting the fitness assay
Here we show that our method is efficient at addressing
the contribution of genetic variation on a specific trait,
herein loss of germline RNAi sensitivity. We think that
the Fitness Assay will be useful to other groups interested
in identifying the contribution that diverse genotypes
may have to their phenotypes of interest. This may
involve different treatments such as environmental stress
or chemical compounds. The Fitness Assay is easy to
implement in any C. elegans laboratory, but future users
need to take into account two critical parameters for
future adaptations of the fitness assay: the number of
worms and the quantity of food. These parameters need
to be optimized, in particular for strains displaying a low
brood size or lethality.
For our purpose, the worms were seeded manually,
but a multiwell dispenser could also be used. This appa-
ratus can process a 96-well plate in about 10 seconds,
but tends to be more variable than the manual method
using a single channel pipette (+/- 4.5 versus +/- 3
worms, respectively). We aimed at seeding 20 L1 worms
per well for our experiments, and used duplicates for
the manual method, however when using the multiwell
dispenser we performed the experiments in triplicate.
We directly tested the efficiency of our assay using the
multiwell dispenser by performing six RNAi treatments
(lin-31, rab-5, smo-1, par-1, par-6, and mel-26)o v e r3 8
RILs. We found that we can still map a QTL at the
ppw-1 locus for smo-1, par-1, par-6 and mel-26 RNAi
treatments (Additional file 2, Figure S1). This confirms
that the multiwell dispenser can also be used to seed
the worms to perform the Fitness Assay. Even though
not tested here, it is very likely that using a worm sorter,
such as the COPAS (Union Biometrica), could reduce or
perhaps eliminate the worm number issue and increase
resolution.
The number of worms is an important factor in the
Fitness Assay, but to what extent can it affect the inter-
pretation of the data? To answer this point, we next
addressed the sensitivity limit of the Fitness Assay by
assessing the effect of worm numbers on the Fitness
Curves (Figure 6A and 6B). We have found that if the
number of worms seeded has a variation of +/- 5 and
that the average number of worms is 20, the variation
produced on the slopes is +/- 0.0025 OD/hours (Figure
6C). Hence, changes within that range must be repeated/
checked since the effect may be due to the variation on
the number of worms seeded. On the other hand, an
effect on the slope beyond this variation is very likely to
be attributed to the applied treatment, herein RNAi. In
the experiment using the multiwell dispenser, the effects
observed for RNAi treatments that show a QTL on ppw-
1 are far beyond the variation caused by worm number
variation. For example the four genes smo-1, par-1, par-6,
mel-26, with a QTL on ppw-1 show an allelic difference
for this parameter between the Hawaii and Bristol of
respectively 0.0043, 0.0051, 0.0036, 0.0048 OD/hours,
which is about two fold above the maximum variation
possibly caused by varying worm numbers. We are there-
fore confident that the calculated effects on the Fitness
Assay are caused by RNAi treatments.
Table 1 Three-way analysis of RNAi treatments performed on Bristol (N2) and Hawaii (CB4856)
gene targeted EV vs Target in Bristol EV vs Target in Hawaii P value (Bristol vs Hawaii)
ev - - 0.15
mpk-1 0.80 0.86 0.10
smo-1 9.80E-06 0.74 5.30E-08
par-1 0.04
1 0.74 0.0013
lin-31 0.50 0.35 0.097
let-502 0.09 0.50 0.03
gld-1 0.039 0.79 1.30E-06
par-6 0.022 0.36 0.0025
pos-1 0.007
1 0.67 9.20E-06
rab-5 6.10E-33 4.50E-36 0.23
mel-26 2.18E-09 0.93 1.70E-14
tag-214 2.56E-16 4.90E-29 8.90E-15
The second column indicates differences that can be detected between the RNAi treatment and the control (ev) in Bristol. P values are derived from time points
5 to 9 except for
1, in which time points 6 to 8 were used (see summary statistics). The third column indicates differences that can be detected between the
RNAi treatment and the control (ev) in Hawaii. The last column is a comparison between Bristol and Hawaii.
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Page 5 of 14Another important parameter is the quantity of food.
We determined that for RNAi a starting OD of around
0.8 units is appropriate. We have also found that if RNAi
is performed with half that amount of food, RNAi effects
are affected (Figure 7). Indeed, the differential effect
detected between Hawaii and Bristol disappears when the
worms are treated with pos-1(RNAi) or mel-26(RNAi)
(Figure 7). In summary, the ratio worms versus food is
important and it may need to be adjusted according to
different strains and food sources used.
Sources of variation
As with any technique there is an associated technical
variation. We addressed the extent of this by repeating,
within a same experiment, multiple times the Fitness
Assay. We found this technical variation to be minimal
(Figure 8). However, there is a degree of variation
between experiments (batches) but this is easily
accounted for by systematically adding the reference or
parental strains. We address this point in the materials
and methods section. To sum up, it is critical that each
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Figure 3 The average FCs for Bristol, Hawaii, rde-1 and ppw-1 mutants following empty vector (ev) and eleven RNAi treatments.N 2i s
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Page 6 of 14Fitness Assay experiment is self-contained, i.e.i n c l u d e s
positive and negative controls for the specific treatment,
herein RNAi, and includes the reference strains, herein
Bristol and Hawaii.
Discussion
Here we have presented a new assay that is both cost effi-
cient and easy to set-up in any laboratory. The main
advantage of the Fitness Assay is its ability to distinguish
and quantify the effect of a specific treatment across mul-
tiple genetic backgrounds or genotypes (Figure 1). We
show that this is particularly powerful to identify the
QTL responsible for loss of germline RNAi sensitivity in
RILs generated from Bristol (RNAi sensitive) and Hawaii
(RNAi insensitive) [6-9]. This study provides evidence
that modifiers of this trait remain to be identified. The
method is also versatile and other treatments could be
used to decipher the contribution of natural genetic var-
iation to specific traits, i.e. a drug response.
The Fitness Assay indicates the capacity of an animal
population to eat at a certain rate. This rate is determined
by multiple factors, including the number of progeny, the
level of viability, and the rate of growth. In our selected set
of RNAi, we found that most targeted genes produced a
significant effect on the FCs (Fitness Curves), which is in
accordance with their previously described function. In
addition, using data from Kamath et al, 2003, we found
that most phenotypes, around 75%, are due to embryonic
lethality, a reduced brood size, or a growth defect. Indicat-
ing that the majority of genes that produce a phenotype by
RNAi in Bristol could be identified by our method. We
tested this prediction by targeting 40 genes: 20 known to
produce ‘viability-related’ defects, and 20 with no ‘viabi-
lity-related’ defects reported by [1]. However, these latter
20 targets have been shown to have functions associated
with signaling pathways, apoptosis or transcription (see
Wormbase). We found that 75% of the genes required for
viability produced a phenotype in the Fitness Assay, indi-
c a t i n gt h a tm o s tR N A it r e a t m e n t st h a tp r o d u c ea‘viabi-
lity-related’ phenotype would also produce a phenotype in
the Fitness Assay (Additional file 3, Figure S2). Using the
other set of targeted genes, we found that 60% of the
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and CB, known to be involved in germline RNAi sensitivity [9]. The genome-wide threshold (0.05 after 1000 permutations) is indicated by the
horizontal dashed red line. The part of the QTL profile below the threshold was plotted on a grey background. For both the QTL calculations
and threshold determination see methods. Critically, a shared QTL close to the ppw-1 locus is observed between mel-26(RNAi), pos-1(RNAi), par-1
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Page 7 of 14RNAi treatments have no effect. Interestingly, the remain-
ing 40% producing an effect on the Fitness Assay have
been shown to play roles in WNT signaling (lin-44),
nuclear excision repair (xpg-1), Notch signaling (sup-17
and aph-1), apoptosis (ikb-1 and vps-18), translational
repression (fbf-1), and transcription (mab-5) (Additional
file 4, Figure S3). Collectively, these data indicate that the
phenotypes identified using the Fitness Assay mostly over-
lap with the data from Kamath et al. 2003 [1] and that
overall if we were to re-perform a genome-wide screen, we
would miss some, but also detect a few new ones.
Even though phenotypes confined to non-viable organs
such as the vulva could be missed by our method, the sig-
naling pathways involved are often functional in other
organs, and these organs may be required to maintain
viability. For example, vulval development requires the
RAS signaling pathway, but this pathway is also essential
to the development of the excretory cell; and a malfunc-
tion of the excretory cell will cause larval lethality [13].
The Fitness Assay can identify this phenotype. There are
alternatives methods that provide high-resolution pheno-
typic analysis. For example, high throughput image analy-
sis increases phenotypic information, albeit at a reduced
throughput [14,15]. However, most C. elegans labora-
tories do not have an up and running automated image-
capture system. For these laboratories, the Fitness Assay
remains the affordable option.
Conclusions
In summary, this is the first study that shows that RNAi
effects can be quantified in C. elegans.T h i si si m p o r t a n t
since it will allow us to understand the contribution of
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Figure 5 RNAi sensitivity is a complex trait mostly associated to ppw-1 polymorphisms. A) We genotyped 31 RILs at the ppw-1 locus and
addressed whether each of these RILs are RNAi sensitive or not using FCs from mel-26(RNAi), pos-1(RNAi), par-1(RNAi), smo-1(RNAi), par-6(RNAi),
and gld-1(RNAi). This analysis has revealed that 25.8% of RILs cannot be categorized as such, underlying that the RNAi sensitive trait is complex.
However, 74.2% of these could be categorized as either N2-like or CB-like. B) From the RILs that can be categorized, most cases (82,6%), can be
associated to the correct ppw-1 allele. On the other hand, only 17.4% of the cases are not significantly associated with ppw-1. Therefore, ppw-1 is
a strong predictor of RNAi sensitivity, but not the only one.
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Page 8 of 14diverse genetic backgrounds to complex traits. For exam-
ple, there is the concept that medicine should be perso-
nalized, in part because of genetic variation between
humans. Perhaps fundamental principles of genetic varia-
tion could be derived from studies performed in Recom-
binant Inbred Lines in C. elegans,a n dt h e s ec o u l dh e l p
develop the field of personalized medicine research.
Methods
Experimental set-up and timeline
The Fitness Assay takes two weeks from inoculation of the
worms to the statistical analysis of the FCs (Fitness
Curves) generated (Figure 9). Briefly, we used L1 worms
seeded at about 20 worms per well and performed the
experiment in duplicate. It is critical to avoid bacterial or
fungal infection since these will affect the readings. We
always read the optical density (OD) at the start of the
experiment (Day 5) and the following days as indicated in
Figure 9A. We also found that the food consumption rate
is very low between day 7 and day 8, therefore readings at
these time points can be omitted without affecting the
analysis. At days 11 and 12, we performed a visual inspec-
tion under the dissecting microscope to ensure that the
experiment is of a good standard, i.e. shows no sign of
contamination or infection. If this happens, normally most
plates and wells are affected. At the end, healthy worms
produce a characteristic FC (Figure 9B, left panel). Worms
subjected to RNAi treatments causing sterility, embryonic
lethality, low brood size or slow growing phenotypes will
produce FCs that lose this characteristic shape (Figure 9B,
right panel). Hence the Fitness Assay principle is that nor-
mal worms will reproduce and consume their food at a
different rate (i.e. faster) than worms displaying pheno-
types that affect viability, fertility and growth rate.
Strains and growth conditions
Wild type C. elegans strains (N2 Bristol and CB4856
Hawaii) were used. Other strains: NL2550 ppw-1(2505) I
and WM27 rde-1(ne219) V. For QTL mapping we used a
total of 56 Recombinant Inbred Lines (RILs) generated
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Figure 6 Effect of number of worms seeded on the Fitness Assay. A) Color of the FCs represent the number of worms. Colored dots
represent the time-points. Grey area shows the time where the slopes of the curves are most distinctive for the number of worms. B) The slope
of the linear relation between worm-number and relative OD is the steepest at 72 and 96 hours. Therefore the time frame between 24 and 96
hours is most distinctive for the number of worms when the slope of the curves is used. C) Number of worms plotted against slope of the
relative OD between 24 and 96 hours. The variation in decrease of OD per hour is between approximately -0.025 and -0.0175 when 20 +/- 5 are
taken. The maximum possible variation by different worm number is +/- 0.0025 OD per hour. From the linear relation of the slope and the
number of worms one can calculate ‘a comparable number of worms’. We explained the slope by the number of worms with a linear model.
The standard deviation of the effect of the number of worms on the slope divided by the mean effect of the number of worms on the slope
give a factor that can be used to determine a comparable number of worms. For the linear model this factor was 0.29. For example if 1sd
deviation from the mean slope is accepted for a mean of 20 worms any number between 20 -/+ 5.8 can be used.
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Page 9 of 14from a cross between Bristol and Hawaii, of which 27 are
partly described in [6-8]. We added 29 newly generated
RILs, the genotype of each RIL used is described in Addi-
tional file 1, Table S1. All strains were maintained on E.
coli OP50-seeded Nematode Growth Medium (NGM)
plates as previously described [16]. All experiments were
conducted at 20°C.
RNAi by feeding in liquid 96-well format
1. Preparation and induction of RNAi bacteria
Inoculate RNAi bacteria into 1 ml of LB containing 100
μg/ml ampicillin in a deep 96-well plate (BD Biosciences
353966) and incubate overnight at 37°C in a shaking
incubator at 250 rpm. To induce the production of
dsRNA add IPTG to a final concentration of 4 mM and
incubate at 37°C for 1 hr in a shaking incubator at
250 rpm. After 1 hr pellet the bacteria by centrifugation
at 4000 rpm for 5 mins. Resuspend bacterial pellets in
200 μl S-medium containing 100 μg/ml ampicillin and
4 mM IPTG [2].
2. Preparation of worm strains
On the day prior to setting up RNAi by feeding in liquid
bleach gravid adults and hatch embryos overnight in M9
buffer to obtain synchronized L1 population. The
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Figure 7 Loss of RNAi effects if the initial concentration of food is too low. Bristol or Hawaii worms were RNAi-treated with empty vector (ev),
lin-31, pos-1 or mel-26, as indicated. Both pos-1(RNAi) and mel-26(RNAi) effects were lost if about half the initial concentration of food was used.
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Page 10 of 14following day pellet synchronized L1 worms by centrifu-
gation at 4000 rpm for 1.5 mins and resuspend in M9
for a concentration of approximately 20 L1 worms per 5
μl of M9 buffer.
3. RNAi by feeding in liquid
For direct comparisons to be made between strains
under study then approximately 20 synchronized L1
worms should be added to each well of a 96-well plate
(Corning
® Costar
® CLS3596) in 5 μlo fM 9b u f f e r
(either with a pipette or with the multiwell dispenser).
Immediately afterwards add 60 μl of the resuspended
RNAi bacteria in S-medium (from 200 μl volume). Per-
form all RNAi experiments in triplicate (therefore using
180 μl out of the 200 μl bacterial resuspension). Incu-
bate 96-well plates in a humidity chamber at 20°C for
the duration of the experiment.
4. OD measurements using plate reader
Measure the absorbance of the triplicate 96-well plates
at 600 nm using a plate reader (Biotek
® EL808) between
0 hrs - 192 hrs (0 - 8 days).
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Figure 8 Technical reproducibility of the Fitness Assay using Bristol and Hawaii. Both strains were seeded in separate 96-well plates and
curves were derived for each well. Bacteria blanks are wells without worms, and media blanks are wells without worms and bacteria. This shows
that bacteria do not grow or die significantly without worms and that the worms’ absorbance at 600 nm is slight.
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Page 11 of 14Normalization of FC data (with unequal start ODs)
Within an RNAi treatment the sources of variation could
be either technical or genotypic. When testing RILs our
interest is in the genotypic variation, therefore it is desir-
able to correct for some of the technical variation. Each of
our experiments was performed in triplicate, always
including Hawaii and Bristol as reference strains, and addi-
tionally included a row dedicated to RNAi bacteria with-
out worms (bacteria blank). Hence, controlling for
contamination and spurious bacterial growth, respectively.
We observed that variation of bacterial growth (without
worms) is minimal between different replicas, experiments
or treatments. However, the starting ODs can vary (mean:
0.79 sd: 0.065). Therefore, we investigated if the bacterial
growth was affected by the start OD. The 312 growth
curves of all the batches of the RNAi bacteria without the
worms were taken together and the source of variation
studied by an anova. The linear model used was: “y(OD) ~
x(time) + x(time):x(start OD)”. This showed that, although
the starting OD is a highly significant (p < 1*10
-16) source
of variation in the bacterial growth curves the effect size is
minimal. The growth curves are nearly parallel and indi-
cate no significant bacterial growth. However, to correct
for the variation observed between starting OD, we
divided the raw ODs of all time-points by the OD of
the first time-point. In this way all curves start at relative
OD of 1.
The start OD of the bacterial suspensions in which the
worms were exposed to RNAi were also different (mean:
0.83; sd: 0.069). Above we have shown that this could
influence the FCs. To normalize and correct for this dif-
ference, we compared the significance and the effect of
the start OD on the variation found in the uncorrected
and the start OD corrected FCs. All the 160 empty vector
FCs were taken together and used in an anova. The linear
model used was: “y(OD) ~ x(time) + x(time):x(start OD)”.
Both the significance and the effect of the start OD inter-
action with the slope of the FCs were lower when the
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Figure 9 Schematic representation of the Fitness Assay. A) Timeline of the Fitness Assay. About two weeks should be allowed from the
inoculation of worms from which synchronized L1s will derive to the complete analysis of the data. B) Depiction of the Fitness Curves (FCs)
produced by wild type worms (left) or sick worms (right). Different FCs from sick worms have been observed. This seems to depend on the
penetrance and the type of phenotypes, e.g. low brood sizes, slow growth, embryonic lethality or sterility. C) Pictures of the N2 worms seeded
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Page 12 of 14FCs were corrected by dividing by the start OD (sig:
1.8*10
-28 ® 5.6*10
-8 ; eff: 5.4*10
-3 ® 3.0*10
-3). A similar
reduction of the role of the start OD was found after cor-
rection for specific RNAi used (data not shown).
We further investigated the effect of the correction of
the ODs on genotype as an explanatory factor for the
v a r i a t i o ni nt h ef e e d i n gc u r v e s .A l lt h eR N A id a t aw a s
analyzed together in an anova. The model used in the
anova was: “y(OD) ~ x(time) + x(genotype) + x(RNAi) +
x(time):x(start OD)”. The start OD is far less significant
after correction whereas the genotype as source of the
variation is as significant as when the uncorrected values
are used. We conclude that it is best to start with equal
amounts of food (start OD) but since this is not always
possible, it is beneficial to correct for the start OD when
analyzing the feeding rate dynamics.
Differences between the FC signatures of Empty Vector
and RNAi Treatment and between the FC signatures of
Bristol and Hawaii
We calculated the significance of the difference between
the FC curves of empty vector (ev) and RNAi treatments
or between N2 and CB by a chi-square test. The indivi-
dual replicates of the samples under comparison are
taken together, normalized and the mean relative OD per
time point is calculated. Then for each replicate it is
scored per time point for whether the relative OD is
above or below the mean. The sum of scores is taken and
(as an example) a matrix is built (Table 2). This matrix is
used to perform a chi-square test. For example, if sam-
ples 1 and 2 have similar values, the chi-square test will
indicate that they are not statistically different. On the
other hand, if samples 1 and 2 have different values, the
test will indicate that they are statistically different.
Genotyping the new recombinant inbred lines
The new recombinant inbred lines were genotyped for 96
SNPs by Illumina “Golden gate” SNP genotyping [17]
(Additional file 1, Table S1). SNPs correspond to pre-
viously used SNPs to genotype 80 RILs [6]. Information
from Illumina can be found at: (http://www.illumina.
com/technology/goldengate_genotyping_assay.ilmn)
QTL mapping
All FC data were normalized per RNAi treatment. ODs
per time point of all experiments were divided by the
average start OD. In this way all RNAi treatments had a
relative start OD of 1 in all replicate experiments. We
calculated the significance of each of the 121 markers of
the N2/CB RIL population (partly described in [6-8]) by
a linear model for each of the individual RNAi treat-
ments and the empty vector (ev). With this linear model
the QTLs are calculated by explaining the variation in
FCs by start OD, time and marker (y(OD)) ~ x(time) +
x(time):x(startOD) + x(marker). All measured FCs were
used and only the approximate linear part of the FC was
used (time-points: 24 to 196). We used 1000 permuta-
tion per RNAi treatment to determine a genome-wide
-log10(p) threshold of 0.05. The FCs were randomized
over the RILs for each round of QTL mapping in the
permutation test. The QTL profiles were collected and
for each profile the most significant score was put in a
list. This list was ordered and the 50
th highest value per
RNAi treatment was used as the threshold.
QTL mapping for the 6 RNAi treatments using the
multiwell dispenser (Additional file 2, Figure S1) was
done by calculating the slopes of the FCs over time-
points 2 to 5 (24, 96, 120 and 144 hours) of the three
replicas and than take the average per genotype. We
used 38 RILs to calculate the QTLs with a single marker
model: y(mean slope)~x(marker).
Comparing FCs of individual RILs to Bristol and Hawaii
The FCs of 32 individual RILs, for which we sequenced
ppw-1, were compared to the FCs of Bristol and Hawaii
by a chi-square test. Averages per strain per time-point
were calculated and normalized by dividing by the start
OD. The FCs were further transformed to % OD of the
normalized start OD. Two separate tests were per-
formed for the RILs FCs against the Bristol’sF C sa n d
Hawaii’s FCs.
Statistical summary
As with any high-throughput experiment, the Fitness
Assay generates large quantities of data. The nature of
this data enables many types of detailed analysis. But to
be used as a truly high-throughput method, a simple
robust type of analysis needs to be applied. Also a soft-
ware environment that enables high-throughput of statis-
tical tests is recommended. The simplest level of analysis
is to reveal the most severe RNAi effects. To this end, we
used a t-test, which is performed on the relative ODs of
the last time point(s). The next level of analysis aims at
detecting less severe RNAi effects, which tend to affect
the middle part of the curves. We found that comparing
slopes using a t-test reflects the RNAi treatment effects
better. Alternatively, a chi-square test can be used on the
mean curve of the two samples. The time points of the
individual replicates are tested to be above or below the
overall mean and summed per treatment. The advantage
Table 2 Matrix used to perform a chi-square test
< mean > mean
sample 1 12 24
sample 2 30 6
The (< mean) indicates the number of replicates below the mean and the (>
mean) indicates the number of replicates above the mean.
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Page 13 of 14of this latter method is that it can be used regardless of
the shape of the curve and that it is easily adjusted to a
specific part of the curve. In summary, many different
tests can be applied to analyze the FCs, but in most cases
simple tests are sufficient to detect RNAi treatments or
genotypes effects.
Additional material
Additional file 1: Newly generated recombinant inbred lines
between Bristol and Hawaii. The new RILs have been genotyped using
the indicated markers Table S1. Newly generated recombinant inbred
lines between Bristol and Hawaii
Additional file 2: QTL profiles of six RNAi treatments performed
using a multiwell dispenser. QTL mapping of ppw-1 using 38 RILs
Figure S1. QTL profiles of six RNAi treatments performed using a
multiwell dispenser. QTLs were calculated on the slope of the FCs. The
slopes were derived using time-points 2 to 5 and averaged per RIL.
Thresholds (0.05) were determined by 300 permutations per treatment
and are shown as a red horizontal line. The physical position of ppw-1 is
indicated by a green dot. The RNAi treatment is indicated in the grey box.
Additional file 3: 20 randomly selected RNAi treatments predicted
to affect viability. Fitness Curves of RNAi treatments Figure S2.2 0
randomly selected RNAi treatments predicted to affect viability by RNAi
according to [1]. Shown are the FCs of RNAi treatments (blue line)
compared to empty vector (grey line). The difference between the RNAi
effect and the control empty vector (ev) is shown in yellow. The RNAi
treatment on N2 is indicated in the grey box. Individual measurements
are shown as dots, blue for RNAi treatments and grey for ev.
Additional file 4: 20 randomly selected RNAi treatments predicted
to NOT affect viability. Fitness Curves of RNAi treatments Figure S3.2 0
randomly selected RNAi treatments predicted to NOT affect viability by
RNAi according to [1]. Shown are the FCs of RNAi treatments (blue line)
compared to empty vector (grey line). The difference between the RNAi
effect and the control empty vector (ev) is shown in yellow. The RNAi
treatment on N2 is indicated in the grey box. Individual measurements
are shown as dots, blue for RNAi treatments and grey for ev.
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